CFSE labeling (1 μM) and flow cytometry analysis were performed as previously described [30]. We thank Stephen Cobbold for the kind gift of YTS 177.4 antibody, Corinne Cordier and Jérôme

Mégret for cell sorting. This work was supported by the Association Française contre les Myopathies and the Agence Nationale de la Recherche (ANR-11-JSV3). R428 cell line M. Carpentier, P. Chappert, and M. Lalfer were supported by the French Ministry of Research. C. Kuhn was supported by the Fondation pour la Recherche Médicale (FRM). The authors declare no financial or commercial conflict of interest. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. “
“Interleukin-21 (IL-21) exerts critical functions in T helper type 17 (Th17) cell development. However, the effect of IL-21 on the differentiation of IL-22-producing T cells is not clear. Here we showed that IL-21 induced the differentiation of human naive CD8+ T cells into Tc22 cells without the expression of IL-17. The addition of transforming growth factor-β inhibited the production of IL-22 but induced the production of IL-17. Both IL-15 and IL-2 induced interferon-γ production

but did not induce differentiation of Tc22, which suggests that common γ-chain signals are not specific to promote IL-22 synthesis. The IL-21 induced naive CD8+ Fulvestrant supplier T cells to produce IL-22 in greater amounts than memory CD8+ T cells. In addition, we demonstrated that IL-21 promoted the proliferation and increased the expression of IL-21 receptors on activated naive CD8+ T cells. Furthermore, IL-21 increased the expression of granzyme B molecules. Analysis of molecular mechanisms indicated that IL-21 induced phosphorylation of signal transducers and activators of transcription 1, 3 and 5 in CD8+ T cells. Overall, our data indicated that IL-21, Anacetrapib an effector cytokine produced by CD4+ T cells,

might mediate the cross-talk between CD4+ and CD8+ T cells through the production of IL-22. Interleukin 21 (IL-21) is a recently identified member of the common γ-chain (γc) -signalling family of cytokines that includes IL-2, IL-7 and IL-15.1 Interleukin-21 is an effector cytokine that is produced by various T helper cell subsets, including T follicular helper cells, T helper type 17 (Th17), Th2 and Th1 cells, and natural killer T cells.2,3 The functional IL-21 receptor consists of IL-21R and γc IL-21R is expressed on T cells, B cells, natural killer cells, dendritic cells, macrophages and epithelial cells, indicating roles of IL-21 in both innate and adaptive immune responses.4 Interleukin-21 signals via the janus kinase–signal transducers and activators of transcription (JAK-STAT) pathway.